Capital Research Global Investors 13D/13G Filings for CONMED Corporation (CNMD)

Capital Research Global Investors 13D and 13G filings for CONMED Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-13
10:29 am
Sale
2025-09-3013GCONMED CORPORATION
CNMD
Capital Research Global Investors1,032,733
3.300%
-511,809decrease
(-33.14%)
Filing
2024-11-12
12:53 pm
Sale
2024-11-0713GCONMED CORPORATION
CNMD
Capital Research Global Investors1,544,542
5.000%
-1,212,566decrease
(-43.98%)
Filing
2024-02-09
5:49 pm
Purchase
2024-02-0713GCONMED CORPORATION
CNMD
Capital Research Global Investors2,757,108
9.000%
564,714increase
(+25.76%)
Filing
2023-02-13
3:32 pm
Purchase
2023-02-1413GCONMED CORPORATION
CNMD
Capital Research Global Investors2,192,394
7.200%
1,474,094increase
(+205.22%)
Filing